The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Erm no Roger. Read the RNS on the funding grant details and given the funding description, it will be significantly more than 100k per annum.
I think we should hear very soon on the details of the devote grant and also hopefully UKCA approval.
Yes plenty to be updated on. New month tomorrow so let's hope the news flow starts soon.
Didn't you post yesterday?
Roger , you really do talk a lot of twaddle! So many inaccuracies in your latest essay and deliberately misleading....for instance the company has already told us they are not spending any money on future development of future assays but all monthly costs are devoted to the commercialisation of AIHL and the stroke test. Re RF they invest in companies they don't take them over. Do your research before posting false rumours!!!
Roger 65. The company cannot release exact details of their Devote funding grant yet because the projects have not been publicly announced by Innovate UK.
Who knows this could the week when positive news updates start happening?
Contradictions everywhere with SS. He may invest after another fundraise (he thinks in Dec and Jan) but then states they won't be selling anything for three years and won't break even for five. Utter drivel.
A lot will depend when the bull runs starts in the run up to the stroke NICE recommendation. But before end Nov anyway we should have lots of positive news updates anyway, so I think in the 35p to 40p range.
Stocksaint ...you seem to have conveniently forgotten that in the recent NICE guidance on future data collection, they clearly stated that funding would be available for further geographical roll outs of AIHL.
Roger, look at the overall number of RNS' on AIM this month compared with previous months. Its a fraction. This may come as a surprise to you but August is the quietest month for news, regulatory approvals, company updates etc etc.
I think a lot of news is (over) due and given August is generally not a month to disclose good news, we could hear a positive news flow in September . Plus in the 31st March RNS re the RF deal, there was mention of a 6th month news flow, which would take us until end Sept.
Agreed Stephen. September promises to be a very exciting month with UKCA news, confirmation of details of devote funding etc etc.
This will fly soon given all the potential good news flow due.
That was a very interesting DB post Nissan highlighted earlier - he talked about funding received for Dx products, not just one. He also talked about the 'cash being good', so perhaps our allocation is a lot more significant than the sums that have been previously talked about?
Its very obvious that to meet the NICE requirements on data, the test will need to be rolled out extensively across the NHS, otherwise the company will not be able to provide the data. NICE have stated that funding (although competitive) will be available for this geographical roll out to happen.
Thanks Eureka. Would be great to receive official confirmation from the company of this soon.
Jimi is dead right with his NICE interpretation. We can sell across the NHS now and last week were told in various posts that there was strong interest across the health service for the test.
The first whiff of international sales, we should see the SP react very positively .
The Austrian news is very exciting. I think they were the first international distributor to be announced so would be good to get an update on last week's news.